top of page

NEURODEGENERATION

TOPIC
SUB-TOPIC
THERAPY
TRIAL

Alzheimer's disease

Anti-amyloid MAbs

Lecanemab

Clarity AD

Lecanemab slows progression of Alzheimer's disease.

Clarity AD

Donanemab

TRAILBLAZER-ALZ-2

Details coming soon.

TRAILBLAZER-ALZ-2

Other

Donepezil

Seltzer, 2004

Details coming soon.

Seltzer, 2004

More trials to be added in due course.

An ongoing project between Dr. Wei Jia Zhang, William Law, and the St. George's Hospital Neuro/Stroke Journal Club.

 

Disclaimer: this website is a work in progress. Final website design and content is subject to change.

​

Contact:

helloneurotrials@gmail.com

bottom of page